Management

Scientific Advisory Board

Prof. Peter J. Barnes, M.A., D.M., D.Sc., FRCP, Imperial College School of Medicine, London, UK    Pulmonary diseases  

 

Prof. David Benditt, M.D., University of Minnesota Medical School, Minneapolis, MN

Cardiac electrophysiology, neurally-mediated syncope

 

Prof. Francesco DiVirgilio, M.D., University of Ferrara, Ferrara, Italy       

P2 receptors in immunology

 

Daniel Flammang, M.D., Centre Hospitalier d'Angouleme,  Angouleme, France 

ATP in the management of patients with syncope 

 

Prof. Pasquale Patrizio, M.D., Yale University-Fertility Center, New Haven, CT, USA

Andrology, male fertility

 

Jane Kinsel, Ph.D., MBA, Boston University, Boston, MA                  

Pharma industry, drug development

 

Donald A. McAfee, Ph.D., VP New Product Development,  Cardiome Pharma Corp., Vancouver, B.C., Canada      Biopharmacuetical industry, neurophysiology

 

Prof. Riccardo Polosa, M.D., Ph.D., University of Catania, Catania, Italy.

Chronic obstructive pulmonary disorders

Copyright © 2008 Duska Therapeutics, Inc. 1999-2008 All rights reserved.

 

Duska Therapeutics

info@duskatherapeutics.com

Promising New Medicines